Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease results from a phase-3 clinical trial program /
BACKGROUND: Iron deficiency anemia (IDA) is frequently seen in inflammatory bowel disease. Traditionally, oral iron supplementation is linked to extensive gastrointestinal side effects and possible disease exacerbation. This multicenter phase-3 study tested the efficacy and safety of ferric maltol,...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2015
|
| Sorozat: | INFLAMMATORY BOWEL DISEASES
21 No. 3 |
| Tárgyszavak: | |
| doi: | 10.1097/MIB.0000000000000314 |
| mtmt: | 2853718 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/27899 |